Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 17,484 | 12,892 | 3,138 | 5,000 | 11,000 |
| Cost of Goods | 2,524 | 2,424 | N/A | N/A | 0 |
| Gross Profit | 14,960 | 10,468 | 1,235 | 5,000 | 11,000 |
| Operating Expenses | 46,925 | 43,628 | 48,713 | 47,824 | 48,401 |
| Operating Income | -31,441 | -32,736 | -45,575 | -42,824 | -37,401 |
| Interest Expense | 3,875 | 3,774 | 3,766 | 5,667 | 4,776 |
| Other Income | 1,824 | -85 | 106,899 | 1,392 | -1,706 |
| Pre-tax Income | -33,492 | -36,595 | 57,558 | -47,099 | -43,883 |
| Income Tax | -6,570 | 11 | 12 | 9 | 11 |
| Net Income Continuous | -26,922 | -36,606 | 57,546 | -47,108 | -43,894 |
| Net Income | $-26,922 | $-36,606 | $57,546 | $-47,108 | $-43,894 |
| EPS Basic Total Ops | -0.84 | -1.17 | 1.91 | -1.55 | -1.45 |
| EPS Basic Continuous Ops | -0.84 | -1.17 | 1.91 | -1.55 | -1.45 |
| EPS Diluted Total Ops | -0.84 | -1.17 | 1.91 | -1.55 | -1.45 |
| EPS Diluted Continuous Ops | -0.84 | -1.17 | 1.91 | -1.55 | -1.45 |
| EBITDA(a) | $-30,943 | $-32,293 | $-45,518 | $-42,646 | $-37,232 |